Gilead HIV Viread Bettered Gilead HBV Hepsera In Curing HBV
By John Wolper
11:17, November 3rd 2007
66 votes
Vote this story
Gilead HIV Viread Bettered Gilead HBV Hepsera In Curing HBV

This Friday, Gilead, a Foster City, California based company, announced its results from two late-stage trials on the efficacy of its Viread on patients with hepatitis B virus (HBV).

The positive results of the 48 week trials were presented at the American Association for the Study of Liver Diseases annual meeting in Boston (Nov. 2-6).

Viread, or tenofovir disoproxil fumarate, is currently the Gilead product prescribed as antiretroviral agent for the treatment of HIV. On the other hand, Gilead has another product Hepsera, or adefovir dipivoxil, which is already approved for treating the liver infection in adults.

In these trials Viread and Hepsera were administrated for 48 weeks in two patients’ groups. One group had HBeAg-negative chronic hepatitis B and the other had HBeAg-positive hepatitis B. Both studies showed superior results in case of treatment with Viread than in case of treatment with especially HBV designed Hepsera. Both medicines were well tolerated by patients in both two studies.

These results help Viread to have the basis to apply to regulatory authorities in the United States and European Union, in order to market Viread as a treatment for HBV.

Chronic hepatitis B is among the top ten causes of mortality, accounting worldwide an estimated number of 400 million people.



© 2007 - 2008 - eFluxMedia
Tags: Gilead, Viread, HBV
dotclear

Other News in

FDA Wants Black Box on Antibiotics, Epilepsy Drugs

FDA Wants Black Box on Antibiotics, Epilepsy Drugs

The U.S. Food and Drug Administration requested black box warnings on fluoroquinolone antibiotics, citing the yet poorly understood risk of tendon rupture. Also, the FDA announced it pushes for black...

Study: Keeping a Food Diary Doubles Weight Loss

A new study shows that the most powerful tools which can be used to lose weight may be as close as a pen and paper. Researchers found out that keeping a food diary helps you eat fewer calories and...

AAP Makes Controversial Recommendations for Statin Use in Kids

AAP Makes Controversial Recommendations for Statin Use in Kids

The American Academy of Pediatrics has changed its guidelines, recommending testing of overweight kids or those with a family history of heart disease for high cholesterol at age two, and prescribing...

IVF Twin Pregnancies No Riskier than Two Single Births

IVF Twin Pregnancies No Riskier than Two Single Births

A U.S. researcher’s argument that twins are a solution for infertile couples who want more than one child was highly criticized by many researchers on Monday who warned of the risks of multiple...

FDA: Epilepsy Drugs Should Carry Suicidal Warning

FDA: Epilepsy Drugs Should Carry Suicidal Warning

The U.S. Food and Drug Administration says epilepsy drugs should carry a “black box” warning about the risk of suicidal thoughts and behavior. The proposal has been released ahead...

dotclear
Latest videos in Health
Hospital death controversy
Zac Web Browser Aims to Focus...

dotclear
Health You are here: Health
» Science   » Health   
E-mail To A Friend Print RSS Text size: Decrease font size Increase font size
dotclear
dotclear
dotclear
Most Popular in Health
Congress Fails To Pass Health Bill Protecting Senior Citizens

» read full story
dotclear

Interested In This Topic?

News Alert will keep you informed. Find out more.
dotclear
Photos Gallery
dotclear
Today's Latest News
FDA Wants Black Box on Antibiotics, Epilepsy DrugsFDA Wants Black Box on Antibiotics, Epilepsy Drugs

» read full story
dotclear